Androscoggin Cardiology — Auburn, Maine

Androscoggin Cardiology is a clinical research site located in Auburn, Maine, United States.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Androscoggin Cardiology has participated in 1 clinical trials.

Therapeutic areas: Atherosclerosis, Coronary Artery Disease, Myocardial Infarction.

Sponsors: AtheroGenics.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Auburn

Browse all research sites in Maine · View every site in Auburn

• Maine Research Associates
• Research Site
• GSK Investigational Site
• Pfizer Investigational Site
• Androscoggin Cardiology Associates
• Central Maine Pulmonary Associates
• Androscoggin Cardiovascular Associates
• Lexicon Investigational Site
• Amarin Investigational Site
• Androscoggin Cardiology Associates-Research
• Central Maine Medical Center
• Boehringer Ingelheim Investigational Site

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Androscoggin Cardiology?

Androscoggin Cardiology has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Androscoggin Cardiology conducted?

Androscoggin Cardiology has 1 clinical trials on record. Their work covers Atherosclerosis, Coronary Artery Disease, Myocardial Infarction.

Is Androscoggin Cardiology accredited by Crixeo Clinical Trials?

Androscoggin Cardiology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Androscoggin Cardiology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.